28.02.2013 Views

The Principles of Clinical Cytogenetics - Extra Materials - Springer

The Principles of Clinical Cytogenetics - Extra Materials - Springer

The Principles of Clinical Cytogenetics - Extra Materials - Springer

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

222 Cynthia Powell<br />

STRUCTURAL ABNORMALITIES OF THE X CHROMOSOME<br />

In addition to the isochromosome Xq commonly found in patients with Turner syndrome, the X<br />

chromosome can be involved in translocations, both balanced and unbalanced, and can also have<br />

deletions and duplications (see Chapter 9).<br />

Structural abnormalities <strong>of</strong> the X in males are generally associated with more severe phenotypic<br />

manifestations than in females. This is partly explained by preferential inactivation <strong>of</strong> the structurally<br />

abnormal X in cases <strong>of</strong> duplications or deletions or in unbalanced X;autosome translocations in<br />

females. In cases <strong>of</strong> balanced X;autosome translocations, there is usually preferential inactivation <strong>of</strong><br />

the normal X chromosome. <strong>The</strong>ories explaining this are discussed in the following paragraphs. Highresolution<br />

chromosome analysis should be performed on females manifesting X-linked disorders to<br />

look for a structural X abnormality.<br />

<strong>The</strong> molecular X inactivation pattern seems to correlate with phenotype in women with structural<br />

abnormalities <strong>of</strong> the X. Completely nonrandom X inactivation <strong>of</strong> the abnormal X is generally associated<br />

with a normal phenotype, whereas those with skewed or random inactivation patterns usually have<br />

nonspecific mental retardation and/or congenital abnormalities. <strong>The</strong> X inactivation status <strong>of</strong> women<br />

with structurally abnormal X chromosomes and an abnormal phenotype should be assayed as part <strong>of</strong> a<br />

routine clinical work-up. <strong>The</strong> phenotype could be correlated with differences in X inactivation ratios<br />

(145). <strong>The</strong>re have been very few reports on the use <strong>of</strong> prenatal X inactivation studies in amniotic fluid<br />

or CVS (146) (see Chapter 12). Studies comparing prenatal and postnatal analysis <strong>of</strong> X inactivation and<br />

their correlation with phenotypic and developmental outcomes are needed before these could be used to<br />

give prognostic information in female fetuses with X-chromosome abnormalities.<br />

X;Autosome Translocations<br />

Balanced Translocations<br />

In females, balanced X-autosome translocations can be divided into four phenotypic categories:<br />

normal phenotype with or without history <strong>of</strong> recurrent miscarriage, gonadal dysfunction with primary<br />

amenorrhea or premature ovarian failure (POF), a known X-linked disorder, or congenital<br />

abnormalities and/or developmental delay (147). <strong>The</strong> reasons for the variable phenotypes are complex<br />

and not fully understood, making genetic counseling in cases <strong>of</strong> prenatal detection <strong>of</strong> these<br />

translocations very difficult.<br />

Translocations involving the X chromosome and an autosome <strong>of</strong>ten lead to primary or secondary<br />

ovarian failure and sometimes Turner syndrome-like features if the translocation occurs within the<br />

critical region <strong>of</strong> Xq13-q26 (148–150). <strong>The</strong>re are several different hypotheses concerning the cause <strong>of</strong><br />

gonadal dysfunction in these cases, including disruption <strong>of</strong> POF-related genes (149,151), a position<br />

effect resulting from local alteration <strong>of</strong> chromatin caused by the translocation (148,150), and incomplete<br />

pairing <strong>of</strong> X chromosomes at pachytene (152). In cases in which the translocated X chromosome<br />

is the inactive X, inactivation will spread from the translocated X segment to the attached autosomal<br />

material, where it will inactivate genes. <strong>The</strong> other X-chromosome segment will remain active. <strong>The</strong>re is<br />

incorrect dosage <strong>of</strong> both autosomal and X-linked genes in these cells, with functional autosomal monosomy<br />

for the derived (X)t(X;aut) chromosome that contained the X inactivation center, and functional<br />

X chromosome disomy for the portion <strong>of</strong> the X chromosome translocated onto the active (autosomal)<br />

reciprocal translocation product (153). <strong>The</strong>re is strong selection against such cells. In general, the normal<br />

X is preferentially inactivated in approximately 75% <strong>of</strong> such patients (153,154). When the translocation<br />

disrupts a gene located on the X chromosome, a female with such a translocation could manifest<br />

a disease condition (155,156). Any mutated genes on the translocated X chromosome will be fully<br />

expressed, as they would be in a male (3). Several X-linked genes have been mapped in this way.<br />

A “critical region” determining normal ovarian function has been hypothesized at Xq13-Xq26<br />

(150,157). <strong>The</strong> majority <strong>of</strong> females with balanced translocations with breakpoints in this region usually<br />

have POF (secondary amenorrhea associated with elevated gonadotropin levels before the age <strong>of</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!